Haft Nicholas (CIK 0001850404)

Latest company ownership

Shares held
10,000
Last filed at
Jun 9, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 20, 2021 Dec 22, 2021 Finch Therapeutics Group, Inc. Director Buy 85.0 +63,850 1.60% $650K
Mar 23, 2021 Mar 25, 2021 Finch Therapeutics Group, Inc. Director Buy 100.0 +882,351 100.00% $15M